<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20200224046605N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2020-04-10</date_registration>
      <primary_sponsor>Mashhad University of Medical Sciences</primary_sponsor>
      <public_title>The effect of Equisetum arvense (Horse tail) on perineal trauma</public_title>
      <acronym></acronym>
      <scientific_title>The effect of Equisetum arvense (Horse tail) on perineal trauma in primiparous women with striae gravidarum</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2020-05-20</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>60</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/46151</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Triple blinded, Placebo: Used, Assignment: Parallel, Purpose: Prevention, Randomization description: Sampling is performed at the obstetric clinic of Omolbanin hospital in Convenience Sampling method based on inclusion and exclusion criteria. Research units are allocated into two intervention and control groups using  simple randomization online, by the sequence created at www.graphpad.com/quickcalcs; The Equisetum arvense (horse tail) and placebo cream, prepared and packaged by a pharmacy advisor professor at the Pharmacological Research Center of Medicinal Plants of Mashhad University of Medical Sciences. the pharmacy advisor professor has assigned a code to each group(only the Pharmacy Advisor professor knows it). Based on the A and B codes assigned to the two groups, the sequence is exemplified AABAB... . In order to allocation concealment, opaque, sealed and in sequentially numbered envelopes  will be used that are kept by the secretary of obstetric clinic, Blinding description: In order to blinding, the Equisetum arvense (horse tail) and placebo cream are provided to the researcher in similar shapes and identical tubes. Each tube has a code that only the pharmacy consultant professor knows about it. Individuals with inclusion criteria are grouped into intervention and control groups according to the sequence based on the codes; and by the end of the study, research units, the researcher, the statistical analyzer and delivery agent will not know about the codes of Equisetum arvense and placebo cream.</study_design>
      <phase>3</phase>
      <hc_freetext>Perineal laceration during delivery.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Individuals in intervention group will apply a knuckle of equisetum arvense cream 3%(which is made in Pharmacological Research Center of Medicinal Plants of Mashhad University of Medical Sciences) in the perineum and the beginning part of vagina by the thumb and forefinger with a reciprocal movement,once at night before sleeping, from the beginning of 37-38 weeks of gestation. This group will receive routine midwifery care until delivery; episiotomy will be performed at delivery time, if indicated, on the discretion of the delivery agent. Intervention 2: Control group: Individuals in control group will apply a knuckle of cold cream (moisturizing cream, which is made in Pharmacological Research Center of Medicinal Plants of Mashhad University of Medical Sciences) in the perineum and the beginning part of  vagina by the thumb and forefinger with a reciprocal movement,once at night before sleeping, from the beginning of 37-38 weeks of gestation. This group will receive routine midwifery care until delivery; episiotomy will be performed at delivery time, if indicated, on the discretion of the delivery agent.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is There is no more information.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Fatemeh Khademolkhamseh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Mashhad College of nursing and midwifery, Ibn Sina Ave., Doctora intersection, Daneshgah Ave.</address>
        <city>Mashhad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9137913199</zip>
        <telephone>+98 51 3859 1511</telephone>
        <email>Khademkf971@mums.ac.ir</email>
        <affiliation>Mashhad University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Samira Ebrahimzadeh Zagami</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Mashhad College of nursing and midwifery, Ibn Sina Ave., Doctora intersection, Daneshgah Ave.</address>
        <city>Mashhad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9137913199</zip>
        <telephone>+98 51 3859 1511</telephone>
        <email>EbrahimzadehZS@mums.ac.ir</email>
        <affiliation>Mashhad University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>primiparous women
18 to 35 years
gestational age 37 to 38 weeks
informed consent to participate in the study
Iranian nationality living in Mashhad
literacy for reading and writing
single pregnancy
cephalic presentation
Total striae score higher than 9 (Moderate to Severe Striae)
Body mass index 18.5 to 30
having Desire To give birth at Omolbanin Hospital</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>35 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria>medical and obstetric problems
vaginal infection
previous vaginal or perineal surgery
drug or alcohol abuse
vegetarian diet
perineal massage
having a history of allergy to herbal medicines</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>O70</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Perineal laceration during delivery</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Prevention</i_code>
      <i_code>Placebo</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Individuals in intervention group will apply a knuckle of equisetum arvense cream 3%(which is made in Pharmacological Research Center of Medicinal Plants of Mashhad University of Medical Sciences) in the perineum and the beginning part of vagina by the thumb and forefinger with a reciprocal movement,once at night before sleeping, from the beginning of 37-38 weeks of gestation. This group will receive routine midwifery care until delivery; episiotomy will be performed at delivery time, if indicated, on the discretion of the delivery agent.</i_keyword>
      <i_keyword>Control group: Individuals in control group will apply a knuckle of cold cream (moisturizing cream, which is made in Pharmacological Research Center of Medicinal Plants of Mashhad University of Medical Sciences) in the perineum and the beginning part of  vagina by the thumb and forefinger with a reciprocal movement,once at night before sleeping, from the beginning of 37-38 weeks of gestation. This group will receive routine midwifery care until delivery; episiotomy will be performed at delivery time, if indicated, on the discretion of the delivery agent.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Perineal laceration degree. Timepoint: Immediately after delivery. Method of measurement: Observation.</prim_outcome>
      <prim_outcome>Perineal laceration length. Timepoint: Immediately after delivery. Method of measurement: Measuring with sterile swap and ruler.</prim_outcome>
      <prim_outcome>Perineal laceration depth. Timepoint: Immediately after delivery. Method of measurement: Measuring with sterile swap and ruler.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Mashhad University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2020-01-27</approval_date>
        <contact_name>Ethics committee of Mashhad University of Medical Sciences</contact_name>
        <contact_address>Assistance of Research and Technology of Mashhad University of Medical Sciences, Qurashi building, Daneshgah avenue Mashhad Razavi Khorasan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
